Predicting Treatment Responses and Disease Progression in Myeloma using Serum Vascular Endothelial Growth Factor and Hepatocyte Growth Factor Levels

References

• Folkman, J. (1971) "Tumor angiogenesis: therapeutic impli-cations", N. Engl. J. Med. 285, 1182–1186.
   PubMed Web of Science ®Google Scholar
• Folkman, J. (1995) "Seminars in Medicine of the Beth Israel Hospital. Boston. Clinical applications of research on angiogene-sis", N. Engl. J. Med. 333, 1757–1763.
   PubMed Web of Science ®Google Scholar
• Folkman, J. (1996) "New perspectives in clinical oncology from angiogenesis research", Eur. J. Cancer 32A, 2534–2539.
   PubMed Web of Science ®Google Scholar
• Weidner, N., Semple, J.P., Welch, W.R. and Folkman, J. (1991) "Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma", N. Engl. J. Med. 324, 1–8.
   PubMed Web of Science ®Google Scholar
• Fox, S.B. (1997) "Tumor angiogenesis and prognosis", Histo-pathology 30, 294–301.
   Google Scholar
• Salven, P., Teerenhovi, L. and Joensuu, H. (1999) "A high pretreatment serum basic fibroblast growth factor concentration is an independent predictor of poor prognosis in non-Hodgkin's lymphoma", Blood 94, 3334–3339.
   PubMed Web of Science ®Google Scholar
• Perez-Atayde, A.R., Salim, SE., Tedrow, U., Connors, S., Allred, E. and Folkman, J. (1997) "Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia", Am. J. Pathol. 150, 815–821.
   PubMed Web of Science ®Google Scholar
• Vacca, A., Di Loreto, M., Di Stefano, R., Gadaleta-Caldarola, G., Iodice, G., Caloro, D. and Dammacco, F. (1995) "Bone marrow of patients with active multiple myeloma: angiogenesis and plasma cell adhesion molecules LFA-1, VLA-4, LAM-1 and CD44", Am. J. Hematol. 50, 9–14.
   PubMed Web of Science ®Google Scholar
• Rajkumar, S.V., Leong, T., Roche, P.C., Fonseca, R., Dispenzieri, A., Lacy, M.Q., Lust, J.A., Witzig, T.E., Kyle, R.A., Gertz, MA. and Greipp, P.R. (2000) "Prognostic value of bone marrow angiogenesis in multiple myeloma", Clin. Cancer Res. 6, 3111–3116.
   PubMed Web of Science ®Google Scholar
• Claffey, K.P. and Robinson, G.S. (1996) "Regulation of VEGFNPF expression in tumor cells: consequences for tumor growth and metastasis", Cancer Metastasis. Rev. 15, 165–176.
   PubMed Web of Science ®Google Scholar
• Claffey, K.P., Brown, L.F., del Aguila, L.F., Tognazzi, K., Yeo, K.T., Manseau, E.J. and Dvorak, H.F. (1996) "Expression of vascular permeability factor/vascular endothelial growth factor by mela-noma cells increases tumor growth, angiogenesis, and experimental metastasis", Cancer Res. 56, 172–181.
   PubMed Web of Science ®Google Scholar
• Folkman, J. (1995) "Angiogenesis in cancer, vascular, rheumatoid and other disease", Nat. Med. 1, 27–31.
   PubMed Web of Science ®Google Scholar
• Kim, K.J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H.S. and Ferrara, N. (1993) "Inhibition of vascular endothelial growth factor induced angiogenesis suppresses tumor growth in vivo", Nature 362, 841–844.
   PubMed Web of Science ®Google Scholar
• Dankbar, B., Padro, T., Leo, R., Feldmann, B., Kropff, M., Mesters, R.M., Serve, H., Berdel, W.E. and Kienast, J. (2000) "Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stroma cell interactions in multiple myeloma", Blood 95, 2630–2636.
   PubMed Web of Science ®Google Scholar
• Podar, K., Tai, Y.T., Davies, FE., Lentzsch, S., Sattler, M., Hideshima, T., Lin, BK., Gupta, D., Shima, Y, Chauhan, D., Mitsiades, C., Raje, N., Richardson, P. and Anderson, K.C. (2001) "Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration", Blood 98, 428–435.
   PubMed Web of Science ®Google Scholar
• Bussolino, F., Di Renzo, M.F., Ziche, M., Bocchietto, E., Olivero, M., Naldini, L., Gaudino, G., Tamagnone, L., Coffer, A. and Comoglio, P.M. (1992) "Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth", J. Cell. Biol. 119, 629–641.
   PubMed Web of Science ®Google Scholar
• Stoker, M., Gherardi, E., Perryman, M. and Gray, J. (1987) "Scatter factor is a fibroblast derived modulator of epithelial cell mobility", Nature 327, 239–242.
   PubMed Web of Science ®Google Scholar
• Taniguchi, T., Toi, M., Inada, K., Imazawa, T., Yamamoto, Y. and Tominaga, T. (1995) "Serum concentrations of hepatocyte growth factor in breast cancer patients", Clin. Cancer Res. 1, 1031–1034.
   PubMed Web of Science ®Google Scholar
• Borest, M., Lien, E., Espevik, T., Helseth, E., Waage, A. and Sundan, A. (1996) "Concomitant expression of hepatocyte growth factor/scatter factor and the receptor c-MET in human myeloma cell lines", J. Biol. Chem. 271, 24655–24661.
   PubMed Web of Science ®Google Scholar
• Borest, M., Hjorth-Hansen, H., Seidel, C., Sundan, A. and Waage, A. (1996) "Hepatocyte growth factor and its receptor c-met in multiple myeloma", Blood 88, 3998–4004.
   PubMed Web of Science ®Google Scholar
• Banks, R.E., Forbes, M.A., Kinsey, SE., Stanley, A., Ingham, E., Walters, C. and Selby, P.J. (1998) "Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology", Br J. Cancer 77, 956–964.
   PubMed Web of Science ®Google Scholar
• Gaudry, M., Bregerie, 0., Andvieu, V., El Benna, J., Pocidalo, MA. and Hakim, J. (1997) "Intracellular pool of vascular endothelial growth factor in human neutrophils", Blood 90, 4153–4161.
   PubMed Web of Science ®Google Scholar
• Sakon, M., Kita, Y, Takeda, Y, Higaki, N., Ohzato, H., Umeshita, K., Hasuike, Y, Gotoh, M. and Monden, M. (1999) "Measurement of hepatocyte growth factor in serum and plasma", Int. J. Clin. Lab. Res. 29, 110–113.
   PubMedGoogle Scholar
• Aguayo, A., Estey, E., Kantarjian, H., Mansouri, T., Gidel, C., Keating, M., Giles, F., Estrov, Z., Barlogie, B. and Albitar, M. (1999) "Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia", Blood 94, 3717–3721.
   PubMed Web of Science ®Google Scholar
• Nakamura, S., Gohda, E., Matsuo, Y, Yamamoto, I. and Minowada, J. (1994) "Significant amount of hepatocyte growth factor detected in blood and bone marrow plasma of leukemia patients", Br J. Haematol. 87, 640–642.
   PubMed Web of Science ®Google Scholar
• Hjorth-Hansen, H., Seidel, C., Lamvik, J., Borset, M., Sundan, A. and Waage, A. (1999) "Elevated serum concentrations of hepatocyte growth factor in acute myelocytic leukemia", Eur. J. Haematol. 62, 129–134.
   PubMed Web of Science ®Google Scholar
• Verstovsek, S., Kantarjian, H., Estey, E., Aguayo, A., Giles, F.J., Manshouri, T., Koller, C., Estrov, Z., Freireich, E., Keating, M. and Albitar, M. (2001) "Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome", Leukemia 15, 1165–1170.
   PubMed Web of Science ®Google Scholar
• Salven, P., Teerenhovi, L. and Joensuu, H. (1997) "A high pretreatment serum vascular endothelial growth factor concen-tration is associated with poor outcome in non-Hodgkin's lymphoma", Blood 90, 3167–3172.
   PubMed Web of Science ®Google Scholar
• Teofili, L., Di Febo, A.L., Pierconti, F., Maggiano, N., Bendandi, M., Rutella, S., Cingolani, A., Di Renzo, N., Musto, P., Pileri, S., Leone, G. and Larocca, L.M. (2001) "Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin disease", Blood 97, 1063–1069.
   PubMed Web of Science ®Google Scholar
• Seidel, C., Borest, M., Turesson, I., Abildgaard, N., Sundan, A. and Waage, A. (1998) "Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study Group", Blood 91, 806–812.
   PubMed Web of Science ®Google Scholar
• Watanabe, 0., Arimura, K., Kitajima, I., Osame, M. and Maruyama, I. (1996) "Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome (letter)", Lancet 347, 702.
   Google Scholar
• Soubrier, M., Dubost, J.J., Serre, A.F., Ristori, J.M., Sauvezie, B., Cathebras, P., Piette, IC., Chapman, A., Authier, F.J. and Gherardi, R.K. (1997) "Growth factor in POEMS syndrome: evidence for a marked increase in circulating vascular endothelial growth factor", Arthritis. Rheum. 40, 786–787.
   PubMed Web of Science ®Google Scholar
• Soubrier, M., Dubost, J.J. and Sauvezie, B. (1994) "POEMS syndrome: a study of 25 cases and a review of the literature. French Study Group on POEMS syndrome", Am. J. Med. 97, 543–553.
   PubMed Web of Science ®Google Scholar
• Di Raimond, F., Azzaro, M.P., Plaumbo, GA., Bagnato, S., Giustolisi, G., Floridia, P., Sortino, G. and Giustolisi, R. (2000) "Angiogenic factors in multiple myeloma: high levels in bone marrow than in peripheral blood", Haematologica 85, 800–805.
   PubMed Web of Science ®Google Scholar
• Iwasaki, T., Hamano, T., Ogata, A., Hashimoto, N., Kitano, M. and Kakishita, E. (2002) "Clinical significance of vascular endothelial growth factor and hepatocyte growth factor in multiple myeloma", Br. J. Haematol. 116, 796–802.
   PubMed Web of Science ®Google Scholar
• Sezer, 0., Jakob, C., Eucker, J., Niemoller, K., Gatz, F., Wernecke, K. and Possinger, K. (2001) "Serum levels of the angiogenic cytokines basic fibroblastic growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma", Eur. J. Haematol. 66, 83–88.
   PubMed Web of Science ®Google Scholar
• Shikano, M., Kushimoto, H., Hasegawa, H., Tomita, M., Hasegawa, M., Murakami, K. and Kawashima, S. (2000) "Usefullness of serum hepatocyte growth factor for the diagnosis of amyloidosis", Intern. Med. 39, 715–719.
   PubMed Web of Science ®Google Scholar
• Martiny-Baron, G. and Marme, D. (1995) "VEGF-mediated tumor angiogenesis: a new target for cancer therapy", Curr. Opin. Biotechnol. 6, 675–680.
   PubMed Web of Science ®Google Scholar
• Thomas, K.A. (1996) "Vascular endothelial growth factor, a potent and selective angiogenic agent", J. Biol. Chem. 271, 603–606.
   PubMed Web of Science ®Google Scholar
• Singhal, S., Mehta, J., Desikan, R., Ayers, D., Roberson, P., Eddlemon, P., Munshi, N., Anaissie, E., Wilson, C., Dhodapkar, M., Zeddis, J. and Barlogie, B. (1999) "Antitumor activity of thalidomide in refractory multiple myeloma", N. Engl. J. Med. 341, 1565–1571.
   PubMed Web of Science ®Google Scholar
• Dmoszynska, A., Bojarska-Junak, A., Domanski, D., Rolinski, J., Hus, M. and Soroka-Wojtaszko, M. (2002) "Production of proangiogenic cytokines during thalidomide treatment of multiple myeloma", Leuk. Lymphoma 43, 401–406.
   PubMed Web of Science ®Google Scholar
• Neben, K., Moehler, T., Kraemer, A., Benner, A., Egerer, G., Ho, A.D. and Goldschmidt, H. (2001) "Response to thalidomide in progressive multiple myeloma is not mediated by inhibition of angiogenic cytokine secretion", Br. J. Haematol. 115, 605–608.
   PubMed Web of Science ®Google Scholar
• Kimiecik, T.E., Keller, J.R., Rosen, E., Vande and Woude, G.F. (1992) "Hepatocyte growth factor is a synergistic factor for the growth of hematopoietic progenitor cells", Blood 80, 2454–2457.
   PubMed Web of Science ®Google Scholar
• Takai, K., Hara, J., Matsumoto, K., Hosoi, G., Osugi, Y, Tawa, A., Okada, S. and Nakamura, T. (1997) "Hepatocyte growth factor is constitutively produced by human bone marrow stromal cells and indirectly promotes hematopoiesis", Blood 89, 1560–1565.
   PubMed Web of Science ®Google Scholar